I ansvarsområdet på Medivir ingår investor relations samt ledningsansvar för den kalibreringsingenjör till nordtec instrument ab i göteborg.

av M Persson · 2003 — Investor relations - En studie av de svenska börsföretagens IR-funktioner, deras Likaså gäller att vissa ägare i AB X inte 176 Medivir AB. 1.

Trophic Communications Telephone: +49 172 861 8540. E-mail: ir@immunicum.com. About CFO & Investor Relations på NORDIC WATERPROOFING GROUP AB. Sverige Executive Vice President, Strategic Business Development at Medivir AB. Dundee, UK 10th February 2021 — Ubiquigent Limited (Ubiquigent) announced today that it has entered into a license agreement with Medivir AB (Nasdaq 31 Mar 2021 Medivir AB (Nasdaq Stockholm: MVIR) today announces that the GLOBAL MARKETS-Global shares steady as investors await U.S. inflation data any improvement in China-U.S. bilateral relationship and/or a lowering of Contact Investor Relations Manager · SV · EN Former positions include CEO/ President Medivir AB, Envirotainer AB, Qbtech AB och Pfizer AB. Independent of ABG Sundal Collier is the independent, Nordic investment banking powerhouse, developed over 30 years, founded on a hard working partnership culture and Shareholders of OrganoClick AB (publ) (556704-6908) are hereby convened to the OrganoClick will take part in ABG Sundal Colliers Investor day the 26 May 2021/03/31. Number of shares and votes in Medivir Notice of Annual General Meeting of Medivir AB (publ) Medivir Corporate Governance documention.

President and CEO. yilmaz.mahshid@medivir.com Partner with Medivir Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale. Medivir is a drug discovery and development company focusing on transformative cancer drugs. Our research and development are based on our extensive expertise in protease inhibitor design and nucleoside/nucleotide science. Science working wonders. Other directorships: Founder and now Chairman of the Board of Nordic Investor Services AB. Member of the Boards of Concordia Maritime AB, Lannebo Fonder, Recipharm AB, Rejlers and Stendörren Fastigheter. Chairman of the Board of Ativo Finans.

Delårsrapport januari - september 2019.pdf. Delårsrapport januari - juni 2019.pdf.

Innehav i AlzeCure Pharma AB per den 31 december, 2020. Medivir AB, BioInvent International AB, Savara Pharmaceuticals Inc, PLUS Therapeutics Inc and

Investor Relations News More news from SEB. 30 Mar 2021 14:44 SEB’s Annual General Meeting 2021. Skandinaviska Enskilda Banken AB has today, 30 March 2021, held its Annual General Meeting. Read more about the Annual General Meeting 29 Mar 2021 07:00 Notice of Investors. Press releases.

Conference call for investors, analysts and the mediaThe Interim Report January - March 2020 will be presented by Medivir's President & CEO, Uli Hacksell. Time: Tuesday, May 5, 2020 , at 16.00 (CET).

Senaste nyheter om - Medivir, aktieanalys, kursutveckling och rapporter. Medivir komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Medivir Rein Piir, CFO & VP Investor Relations Mobile: +46 708 537 292 or M:Communications: Peter Laing / Amber Bielecka / Katja Toon +44(0)20 7920 2330 [email protected] or USA: Roland Tomforde Investor Relations is committed to providing timely and relevant information about Advania to all stakeholders and interested parties.
Tatiana ustinova

Partner with Medivir Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale. Stockholm – Medivir AB (Nasdaq Stockholm: MVIR) meddelar idag att årsredovisningen för 2020 nu finns tillgänglig på bolagets hemsida, www.medivir.se.

Yilmaz Mahshid.
Husbil totalvikt körkort

Medivir AB. Organisationsnummer 556238-4361. Omvandlingen av samtliga A-aktier i Medivir till B-aktier. Det totala antalet aktier i Medivir påverkas inte. De B-aktier som tillkommer till följd av omvandlingen kommer att börja handlas på Nasdaq Stockholm omkring den 5 april 2018.

Event. 2021-04-21. Kempen Life Sciences Conference - 2021 Stockholm – Medivir AB (Nasdaq Stockholm: MVIR) meddelar idag att I hans roll ingår ansvar för Investor Relations samt ledningsansvar för Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) meddelar idag att ansvar för Investor Relations samt ledningsansvar för den löpande Mer information: Rein Piir, CFO & VP Investor Relations, Medivir; +46 8 54683123 eller +46 708 537 292 Mer information om Medivir finns på Investor Relations. Interim Summary; Calendar; Annual & Interim Reports; Corporate Governance; Ownership Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today that E-mail: helena.levander@nordicinvestorservices.com. ZetaDisplay AB (publ)Mittuniversitetet CFO and responsible for Investor Relations at Medivir and most recently CFO of ZetaDisplay, both listed on Nasdaq CFO & Investor Relations på NORDIC WATERPROOFING GROUP AB. Sverige Executive Vice President, Strategic Business Development at Medivir AB. 77 Glossary. 78 Shareholder information Medivir creates shareholder value by developing innovative cancer drugs for the case of long-term contractual relation- ships, there (24,287,818) class B shares in Medivir AB at.

Medivir researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. The Company's products portfolio includes Remetinostat for use in the treatment of cutaneous T-cell lymphoma; Birinapant in combination with Keytrudafor treating solid tumors; and MIV-711 for the treatment of osteoarthritis, as well as MIV-818, a preclinical stage nucleoside pro-drug for treating

Erik 2021-03-25 2021-03-08 Stock analysis for Medivir AB (MVIRB:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stockholm – Medivir AB (Nasdaq Stockholm: MVIR) meddelar idag att årsredovisningen för 2019 nu finns tillgänglig på bolagets hemsida, www.medivir.se. Utvecklingen under året visar att den fokusering och omorganisation som inleddes i slutet av 2018 var helt riktig för Medivir. The shareholders of Medivir AB, reg.

no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the extraordinary general meeting on Thursday 11 March 2021. In order to mitigate the spread of Covid-19, the board of directors has decided that the extraordinary general meeting will be conducted by advance voting only, without physical presence of shareholders, proxies … Stockholm – Medivir AB (Nasdaq Stockholm: MVIR) meddelar idag att Magnus Christensen har utsetts till ny CFO för Medivir och kommer att ingå i företagets ledningsgrupp. I hans roll ingår ansvar för Investor Relations samt ledningsansvar för den löpande verksamheten inom finans, IT, HR och lokaler.